Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Istradefylline

Istradefylline

pharmaceutical raw materials
Istradefylline structure

Istradefylline 

structure
  • CAS No:

    155270-99-8

  • Formula:

    C20H24N4O4

  • Chemical Name:

    Istradefylline

  • Synonyms:

    1H-Purine-2,6-dione,8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-;1H-Purine-2,6-dione,8-[2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-,(E)-;8-[(1E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione;KW 6002;Istradefylline;Nourianz;Nouriast

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

In March 2013, istradefylline (also known as KW-6002) was approved in Japan for adjunctive treatment of Parkinson’s disease (PD). Istradefylline acts by antagonism of the adenosine A2A receptor, which is colocalized with dopamine D2 receptors in the striatum, to enhance dopamine D2-dependent signaling. Istradefylline is a light-sensitive compound and has been evaluated in vitro under low-light conditions to prevent isomerization of the (E)-styryl group and decompos.

Istradefylline Basic Attributes

384.43

384.43

Characteristics

76.9

2.84

white to beige

1.24±0.1 g/cm3(Predicted)

191 °C

601.0±65.0 °C(Predicted)

317.3±34.3 °C

1.598

DMSO: soluble5mg/mL (clear solution)

2-8°C

Safety Information

UN 2811 6.1 / PGIII

3

25

45

T

P301 + P310

H301

Istradefylline Use and Manufacturing

Treatment of Parkinson’s disease (adenosine A 2A receptor antagonist).

Recommended Suppliers of Istradefylline

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.